| Description |
1 online resource (xiv, 377 pages) : illustrations (some color) |
| Series |
Current topics in microbiology and immunology, 0070-217X ; 342 |
|
Current topics in microbiology and immunology ; 342.
|
| Contents |
The Varicella-zoster virus genome -- VZV molecular epidemiology -- Roles of cellular transcription factors in VZV replication -- Effects of Varicella-zoster virus on cell cycle regulatory pathways -- Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases -- VZV ORF 47 serine protein kinase and its viral substrates -- Overview of Varicella-zoster virus glycoproteins gC, gH and gL -- Analysis of the function of glycoproteins E and I and their promoters during VZV replication in virto and in skin and T cell xenografts in the SCID mouse model of VZV pathogenesis -- Varicella-zoster virus glycoprotein M -- Varicella zoster virus immune evasion strategies -- VZV Infection of keratinocytes: production of cell-free infectious virions in vivo -- Varicella-zoster virus T cell tropism and the pathogenesis of skin infection -- Experimental models to study varicella zoster virus infection of neurons -- Molecular characterization of Varicella zoster virus (VZV) in latently infected human ganglia: physical state and abundance of VZV DNA, quantitation of viral transcripts and detection of VZV-specific proteins -- Neurological disease produced by Varicella zoster virus reactivation without rash -- Varicella-zoster virus neurotropism in SCID mouse-human DRG xenografts -- Rodent models of Varicella-zoster virus neurotropism -- Simian Varicella virus: molecular virology -- Simian Varicella virus pathogenesis -- Varicella-zoster virus vaccine : molecular genetics -- VZV T-cell-mediated immunity -- Perspectives on vaccines against Varicella-zoster virus infections |
| Summary |
Varicella-zoster virus is a common human pathogen that causes varicella (chickenpox), establishes latency in sensory nerve ganglia and can reactivate many years later as herpes zoster. VZV is the only human herpesvirus for which vaccines to prevent both primary and recurrent infection are approved and VZV vaccines have had significant public health benefits. These achievements and new directions that are unfolding are described in this review of VZV basic and clinical research |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Print version record |
| Subject |
Varicella-zoster virus.
|
|
Herpesvirus 3, Human
|
|
HEALTH & FITNESS -- Diseases -- Contagious.
|
|
MEDICAL -- Infectious Diseases.
|
|
Varicella-zoster virus
|
| Form |
Electronic book
|
| Author |
Abendroth, Allison
|
|
Arvin, Ann M
|
|
Moffat, Jennifer F
|
| ISBN |
9783642127281 |
|
3642127282 |
|
3642127274 |
|
9783642127274 |
|
